Fort Washington Investment Advisors Inc. OH Sells 368,718 Shares of Doximity, Inc. $DOCS

Posted by Geri Gentry on Oct 16th, 2026

Fort Washington Investment Advisors Inc. OH cut its stake in Doximity, Inc. (NYSE:DOCS – Free Report) by 35.2% in the third quarter, Holdings Channel reports. The institutional investor owned 677,876 shares of the company’s stock after selling 368,718 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Doximity were worth $19,211,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Carmignac Gestion raised its stake in shares of Doximity by 127.8% in the first quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock valued at $100,480,000 after acquiring an additional 2,418,971 shares during the period. Wellington Management Group LLP lifted its holdings in shares of Doximity by 24.7% in the 2nd quarter. Wellington Management Group LLP now owns 3,135,113 shares of the company’s stock worth $65,022,000 after acquiring an additional 621,464 shares during the last quarter. Quantinno Capital Management LP lifted its holdings in shares of Doximity by 420.5% in the 1st quarter. Quantinno Capital Management LP now owns 140,345 shares of the company’s stock worth $3,270,000 after acquiring an additional 113,380 shares during the last quarter. Royal Bank of Canada boosted its stake in shares of Doximity by 28.4% during the 1st quarter. Royal Bank of Canada now owns 206,282 shares of the company’s stock worth $4,806,000 after purchasing an additional 45,618 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Doximity by 32,406.0% during the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 97,843 shares of the company’s stock worth $2,256,000 after purchasing an additional 97,542 shares during the period. 87.19% of the stock is currently owned by institutional investors.

Doximity Stock Up 5.3%

Shares of Doximity stock opened at $31.51 on Friday. The stock’s fifty day moving average is $26.68 and its two-hundred day moving average is $23.58. The company has a market capitalization of $5.62 billion, a PE ratio of 32.88, a price-to-earnings-growth ratio of 23.40 and a beta of 1.22. Doximity, Inc. has a 52 week low of $17.15 and a 52 week high of $71.37.

Doximity (NYSE:DOCS – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.13. Doximity had a return on equity of 18.06% and a net margin of 25.48%. The business had revenue of $156.62 million during the quarter. During the same quarter last year, the business posted $0.36 earnings per share. The firm’s revenue for the quarter was up 7.3% compared to the same quarter last year. As a group, research analysts anticipate that Doximity, Inc. will post 0.74 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. BMO Capital Markets reiterated a “market perform” rating and set a $30.00 price target on shares of Doximity in a report on Friday, August 7th. JPMorgan Chase & Co. increased their price objective on shares of Doximity from $26.00 to $31.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Wolfe Research raised shares of Doximity to an “outperform” rating in a research note on Thursday, August 13th. Canaccord Genuity Group set a $36.00 price objective on shares of Doximity in a research note on Friday, August 7th. Finally, Barclays boosted their target price on Doximity from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Friday, August 21st. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, Doximity presently has a consensus rating of “Hold” and an average price target of $31.95.

Check Out Our Latest Stock Analysis on Doximity

Trending Headlines about Doximity

Here are the key news stories impacting Doximity this week:

Positive Sentiment: Doximity extended its 13-year partnership with U.S. News, expanding tools for physician discovery, appointment booking and hospital rankings. The agreement could support user engagement, patient-access initiatives and longer-term monetization of Doximity’s physician network. Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
Neutral Sentiment: Doximity said it will release fiscal 2027 second-quarter results on November 5. The report will provide investors with an update on revenue growth, advertising demand and profitability following the company’s latest quarter, when revenue rose 7.3% year over year and adjusted earnings exceeded estimates. Doximity to Release Fiscal 2027 Second Quarter Results
Negative Sentiment: Several law firms publicized a securities class action covering investors who purchased DOCS shares from August 8, 2024, through May 13, 2026. The filings allege that Doximity overstated the growth and contribution of its Newsfeed and advertising products while traditional ad formats reportedly lost share to programmatic and social-media competitors. The company’s CEO, former CFO and co-founder/former Chief Strategy Officer Nate Gross are among the named defendants in related allegations. Investors face a November 16, 2026 lead-plaintiff deadline. The announcements are largely duplicative, but they increase headline risk, potential litigation costs and investor concerns about the company’s prior disclosures. Doximity Securities Class Action Announcement

Insider Activity at Doximity

In related news, CAO Siddharth Sitaram sold 2,077 shares of the firm’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $26.02, for a total value of $54,043.54. Following the transaction, the chief accounting officer owned 96,045 shares of the company’s stock, valued at $2,499,090.90. This trade represents a 2.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Wampler sold 2,000 shares of Doximity stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $28.91, for a total transaction of $57,820.00. Following the sale, the director owned 27,923 shares of the company’s stock, valued at $807,253.93. The trade was a 6.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 16,637 shares of company stock valued at $533,688. Company insiders own 31.80% of the company’s stock.

Doximity Profile

(Free Report)

Doximity, Inc operates a digital platform designed for U.S. medical professionals. Its network enables physicians, nurse practitioners, physician assistants and other healthcare providers to connect with colleagues, exchange clinical information and access professional resources.

The company offers tools for telehealth and care coordination, including video and phone-based communication services, as well as digital faxing and secure messaging capabilities. Doximity also provides medical news and research content tailored to healthcare professionals.

Doximity generates additional business through recruiting and marketing solutions that help healthcare organizations reach clinicians and promote employment opportunities, services and products.